Replies to post #32203 on Intellipharmaceutics International Inc. (IPCI)

[doogdilinger]

I would love to be proven wrong mopar but sadly those 2 timeline updates totally remind me of all the times they kept extending their expected Rexista NDA submission.

Unfortunately they no longer have the luxury of any relevant time on their side IMO. So it's my belief that now we know that they're giving a timeline of sometime in the 1st half of 2018 to initiate PODRAS trials that they will not be able to launch those trials ahead of their next offering. I also believe that since they can't even get a meeting with the FDA to go over their HAP studies protocol on their Oxy NDA candidate, that their backs are against the wall on launching those oral and nasal studies prior to their next required offering as well.

And I definitely believe that the FDA is just gonna continue delaying any potential approvals of their Pristiq or Lamictal ANDA's which again puts their backs against the wall on when they'll need to do their next financing offering. Hell even with approvals on these 2 ANDA's, we already know the results of MNK's commercialization endeavors will be a huge disappointment, just as MNK's results on SeroquelXR have been...because MNK continues to try to sell their generics division with no suitors remaining(but 1) to even give them a good offer I might add.

Hey I would love to be proven overly pessimistic at this point...but since we've had since 2009 to see how this company operates and especially how the FDA treats them...to me the fear of when they'll need to do their next financing is real and becoming closer by the day...and if they do have to initiate another offering the market's gonna punish them again and the likelihood of a reverse split becomes the number 1 force driving the negative sentiment(remember the downward pressure from last autumns offering is coming soon too as the 6 month vesting period on those shares expires soon and those shares will surely be immediately dumped as soon as the restriction comes off)...and if a r/s occurs due to the pressure of another offering and IPCI deciding they want to keep their NAZ listing...even good news finally arriving isn't gonna do jack for this stock for at least another 18 to 24 months...and I very much doubt many already long suffering longs are gonna want to stick around and endure 2 more years of pain.

Nothing would please me more than IPCI regaining market and shareholder confidence and this stock trading well above $1 per share again...but to say I'm disappointed on where they're at on their HAP studies and PODRAS trials is putting it mildly. And if IPCI does have to do another financing soon and a reverse split...it's going to be a minimum 2 full years before any long suffering long even has a chance of getting back to the pre reverse split share price levels of $2.50 per share.

Heck all we gotta do is look at PTIE's post reverse split action to see that even with the recent good news on their REMOXY oral & nasal studies...PTIE's post r/s share price is still not back to the pre-reverse split share price levels to know where my pessimism originates if IPCI decides they have to reverse split soon glty

[doogdilinger]

Also mopar, I will definitely give you that the 9 month timeline required for HAP studies completion is just speculation. But the reason I'm personally saying 9 months is based on the fact that I believe in order to even remotely stand a chance of facing another AdCom panel and the panels previously proven vast blue dye concerns...IPCI will have to do both CAT 2 and CAT 3 HAP studies otherwise why even bother! It's not like IPCI doesn't now know that the blue dye was and will continue to be a HUGE issue to panel members!

So yes, there's nothing in stone that says 9 months...but I think collectively we'd all be pretty foolish thinking this company has the 1st clue about completing CAT 2 and 3 HAP studies in a timely manner...especially since we just discovered that even though it's been 6 full months now since their AdCom disaster...and sadly they haven't even been able to sit down with the FDA and go over their protocol parameters on their planned Human and Abuse Potential studies.

So for mgmt. to even suggest that they anticipate completing said HAP studies quickly and being in a position to resubmit their NDA this july or august to me is as overly ambitious as every time they give us a timeline expectation then miss it!

July is only 6 months away, and I for one certainly don't believe for one minute that IPCI's gonna resubmit their OxyContin NDA Candidate to the FDA in this timeframe...and I find it comical that they would even give a 6 month timeframe considering they haven't even sat down with the FDA yet k cheers!

[doogdilinger]

If they can avoid a R/S all of us long time s/h's will stick around I'm sure since we've stuck it out this long already right glta